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M. Thompson*Department of Vascular Surgery, St George’s Hospital, London, UKIntroduction. In 2003, 18% of all admissions to our vascular ward were colonised by MRSA, with an MRSA infection rate
of 10.6%. Standard practice was to segregate patients with proven MRSA from the rest of the patient pool. After a
prospective audit, regression analysis was used to identify factors that could stratify patients into high and low risk for
MRSA colonisation. A change in isolation policy was introduced that segregated patients according to their risk of MRSA
acquisition, and isolated all patients undergoing prosthetic vascular reconstruction. Antibiotic policy was also altered. This
audit reports the impact of these changes on MRSA colonisation and infection rates.
Methods. The MRSA status of patients during 777 in-patient episodes was prospectively recorded during three time spans;
period 1 (November 2002–April 2003) before the change in isolation and antibiotic policy and, periods 2 (August–December
2003) and 3 (October 2004–January 2005) after the change in policy.
Results. Hospital acquired MRSA colonisation was reduced from 10.6% in period 1, to 1.1 and 1.4% in periods 2 and 3,
respectively (p!0.001). Similarly, MRSA infection rates fell from 10.6 to 2.9 and 0.9% over the same time frame (p!
0.001). The most dramatic changes in MRSA infection rates occurred in patients undergoing aneurysm repair (MRSA
infection 30.1% in period 1 vs. 3.9 and 2.9% in periods 2 and 3) and lower limb revascularization (31 vs. 0 vs. 4.2%).
Stepwise regression analysis revealed that the system of isolation was a significant factor reducing MRSA infection and
colonisation rates (p!0.001).
Conclusions. These data demonstrate that a change in infection control policy can significantly reduce MRSA infection in a
vascular unit.Keywords: Vascular surgery; MRSA; Infection; Audit.Introduction
The incidence of hospital acquiredmethicillin resistant
Staphylococcus aureus (MRSA) is continuing to rise
world wide. In the United Kingdom, MRSA continues
to attract significant negative publicity and the
Department of Health publishes league tables of
hospital trusts with respect to their MRSA bacteraemia
rates. These tables broadly demonstrate that specialist
hospitals have higher MRSA rates than general acute
trusts.1 This is of considerable importance to special-
ised vascular units.
MRSA colonisation and infection has become a
feared complication in vascular surgical practice due
to the high morbidity and mortality associated withing author. Matt Thompson, MD, FRCS, Professor of
gery, Department of Vascular Surgery, St George’s
Floor St James Wing, Blackshaw Rd, London SW17
: matt.thompson@stgeorges.nhs.uk
0609+ 07 $35.00/0 q 2006 Elsevier Ltd. All rights resergraft infection. MRSA has become the single most
prevalent organism in patients with complex wound
and graft infections after vascular surgery.2 Patients
with MRSA graft infection have particularly poor
outcomes with mortality and amputation rates being
higher than for other infections.3 In one series, aortic
graft infection was fatal.4
It is, therefore, essential that MRSA colonisation
and infection are reduced within vascular surgical
units. In practice, this has proved difficult as there is a
reservoir of MRSA in community based nursing
homes and ulcer clinics, and these patients are often
admitted to vascular units. Most vascular units have
reported a rise in MRSA infections.5 Patients have
been shown to become colonised with MRSA during
all stages of a hospital admission, but acquisition on
intensive care units and the main vascular ward
appears to be most common events.6 Previous
commentaries have suggested that changes in tra-
ditional vascular isolation policies may have an effectEur J Vasc Endovasc Surg 31, 609–615 (2006)
doi:10.1016/j.ejvs.2005.12.009, available online at http://www.sciencedirect.com onved.
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M. Thompson610on MRSA colonisation, by separating patients at high
and low risk of MRSA colonisation.7
The present study was designed in two phases. The
first phase aimed to determine the factors associated
with MRSA colonisation and infection on a vascular
ward. Having identified these factors, a change in
infection control policy was instituted with the aim of
segregating patients according to their risk of MRSA
colonisation. The effects of this policy change were
then prospectively audited.Fig. 1.MethodsStudy design
The study took place on a regional vascular unit
within an inner London University Hospital. Initially,
a prospective investigation was conducted between
November 2002 and April 2003 to determine the
prevalence of MRSA within the vascular unit and to
identify the factors associated with MRSA colonisation
and infection. A change in infection control policy was
then instituted and the effect of this system on MRSA
infection rates was prospectively analysed during two
subsequent time periods (August–December 2003 and
December 2004–February 2005).Table 1. Factors independently associated with MRSA carriage,
colonisation and infection based on data from November 2002 to
April 2003
MRSA carriage MRSA colonisation MRSA infection
Past history MRSA MRSA carrier MRSA colonisation
Tissue loss Admission ITU Open AAA
Length of stayO
7 days
Lower limb bypass
surgery
Age
All factors are significant to p!0.01, and are presented in order of
significance. Open AAA, open abdominal aortic aneurysm repair.
Variables included in analysis of MRSA infection: age, admission
type (emergency or elective), length of stay, diagnosis (abdominal
aortic aneurysm, neurovascular disease, severe limb ischaemia,
tissue loss, intermittent claudication, varicose veins, other), diabetes,
past history MRSA, operative procedure (open aneurysm repair,
endovascular aneurysm repair, carotid endarterectomy, lower limb
bypass, amputation, PTA, vein surgery), ITU admission, MRSA
carriage.MRSA screening and identification
Patients admitted to the vascular ward were screened
for MRSA colonisation on admission (MRSA carriage),
on return from theatre and/or ITU, and weekly during
the hospital episode. In addition, swabs were obtained
from any clinically indicated site (ulcers, open
wounds, areas of tissue necrosis, sputum, urine,
blood etc.). The MRSA screening swabs were standar-
dised for each patient. Swabbing was performed using
standard bacteriology swabs moistened with sterile
saline. Specific sites examined for screening were the
nose, and perineum. Samples from both anatomical
sites were pooled for microbiological examination.
Episodes of MRSA infection and/or colonisation were
prospectively recorded. MRSA carriage was defined as
isolation of MRSA from pooled screening or site
specific swabs on admission to the vascular unit.
MRSA colonisation was defined by the isolation of
MRSA from pooled swabs in the absence of any
clinical signs or symptoms of infection. MRSA
infection was defined as the isolation of MRSA from
a site associated with tissue destruction or from blood,
urine or sputum cultures. MRSA colonisation andEur J Vasc Endovasc Surg Vol 31, June 2006infection were further defined as to whether theMRSA
was acquired in hospital or in the community.Infection control policy pre-July 2003
The change in infection control policy occurred in July
2003. Before that date the vascular unit ward was
arranged as shown in Fig. 1. The ward consisted of
four bays, two of six beds and two of eight beds. There
were two side rooms. One of the bays was fitted with
closing doors and was used to isolate patients with
MRSA. One bay was used as a higher dependency
area, which predominantly contained patients in the
immediate post-operative period or those requiring a
higher level of care. The two other bays were single
sex, used to separate male and female patients. These
two bays contained patients with the full range of
vascular disorders before, during and after treatment.
The two side rooms were predominantly used for
patients with MRSA who had prosthetic vascular
reconstruction. Patients undergoing vascular surgery
received standard antibiotic prophylaxis with 1.2 g co-
Table 2. Hospital acquired MRSA colonisation for the three time
periods studied, for all patients and by operative procedure
Period 1 Period 2 Period 3 p
All patients 39/367 2/199 3/211 !0.0001
10.6% 1.1% 1.4%
MRSA in Vascular Surgery 611amoxiclav on induction of anaesthesia, followed by
two post-operative doses. Patients with known MRSA
carriage/colonisation were given 1 g of vancomycin
on induction of anaesthesia in addition to the standard
regimen.Open AAA 9/28 0/9 1/14 0.045
32.1% 0% 7.1%
EVAR 2/8 1/17 0/21 0.051
25% 5.9% 0%
All AAA 11/36 1/26 1/35 0.0007
30.1% 3.9% 2.9%
CEA 0/15 0/10 0/11 N/A
0% 0% 0%
Bypass 9/29 0/14 1/24 0.0051
31.0% 0% 4.2%
Amputation 3/21 0/3 0/6 0.54
14.3% 0% 0%
PTA 7/124 1/57 1/48 0.34
5.7% 1.7% 2.1%
Period 1, November 2002–April 2003; period 2, August–December
2003; period 3, October 2004–January 2005. Numbers and percen-
tages are given. Statistical analysis used Fischer’s exact test. Open
AAA, open aneurysm repair; EVAR, endovascular aneurysm repair;
CEA, carotid endarterectomy; bypass, lower limb bypass surgery;
Amputation, major and minor lower limb amputation; PTA,
percutaneous transluminal angioplasty. Only limited breakdown of
the total patient numbers are included, patients with varicose veins,
admission for assessment, those conservatively treated or with
miscellaneous procedures have not been presented separately.Infection control policy post-July 2003
Regression analysis identified factors that were
independently associated with MRSA carriage, colo-
nisation and infection on the vascular unit between
November 2002 and April 2003 (Table 1). These data
were used to develop an infection control policy that
aimed to segregate patients based on their risk of
MRSA carriage/colonisation. The vascular unit ward
was reorganised to reflect this policy (Fig. 2). The
closed bay was utilised for patients whowere screened
negative for MRSA or who had no risk factors for
MRSA carriage or colonisation based on the regression
analysis. In practice, this was used for pre-operative
patients with no history of MRSA or tissue loss;
patients admitted for investigation of abdominal
aneurysms; and post-operative patients screened
negative for MRSA. Two bays were then designated
low and high risk for MRSA carriage/colonisation.
Patients were assigned to these bays by the nursing
staff on an individual basis. The principle of assign-
ment was to segregate patients with high risk of MRSA
carriage/colonisation from those patients having
undergone or likely to undergo prosthetic vascular
reconstruction.
Patients were deemed high risk for MRSA carria-
ge/colonisation if they had a past history of MRSA or
evidence of tissue necrosis. Patients with these risk
factors were admitted to the high risk bay. The low risk
bay contained patients without tissue necrosis or a
past history of MRSA. Post-operative patients were
admitted to this bay following a short (!2 day) ITUSide room High risk / MRSAPost op Side room
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Fig. 2.stay or following lower limb bypass. The isolation
rooms were used for patients without documented
MRSA, but who had significant risk factors for MRSA
(e.g. prolonged ITU stay, lower limb bypassClong pre-
operative length of stay). These patients were screened
and allocated to the appropriate bay when the swab
results were available. The fourth bay was used to
isolate patients with proven MRSA. Patients with
proven MRSA following vascular reconstruction were
admitted to a side room. Nursing staff were allocated
to one bay and did not cross bays.
The antibiotic policy was changed during the same
time period. All patients received a standard regime of
three peri-operative doses of co-amoxiclav, one dose
on induction and two post-operative doses 8 h apart.
Patients with unknown MRSA status, those colonised
with MRSA or those with MRSA infection received 1 g
vancomycin on induction of anaesthesia.Clinical data
Patient demographics were prospectively recorded as
was the mode of admission, clinical diagnosis, and
operative procedure, length of stay, ITU admission,
MRSA status and mode of discharge. The site of anyEur J Vasc Endovasc Surg Vol 31, June 2006
Table 4. MRSA infection rates for the three time periods studied,
for all patients and by operative procedure
M. Thompson612MRSA infection was recorded. The factors entered into
the regression analysis are listed in Table 1.Period 1 Period 2 Period 3 p
All patients 39/367 5/199 2/211 !0.0001
10.6% 2.5% 0.9%
Open AAA 9/28 0/9 1/14 0.042
32.1% 0% 7.1%
EVAR 1/8 0/17 0/21 0.088
12.5% 0% 0%
All AAA 10/36 0/26 1/35 0.0004
27.8% 0% 2.8%
CEA 0/15 0/10 0/11 N/A
0% 0% 0%
Bypass 7/29 2/14 1/24 0.13
24.1% 14.3% 4.2%
Amputation 6/21 0/3 0/6 0.2Statistical analysis
The rates of MRSA carriage, colonisation and infection
are presented as percentages, and compared using
Fischer’s exact test. Identification of risk factors
associated with MRSA status was determined using
stepwise regression analysis with a significance level
of 0.01. Statistical analysis was performed using SPSS
for Windows v13.28.6% 0% 0%
PTA 9/124 1/57 0/48 0.06
7.3% 1.7% 0%
Period 1, November 2002–April 2003; period 2, August–DecemberResults2003; period 3, October 2004–January 2005. Numbers and percen-
tages are given. Statistical analysis used Fischer’s exact test.Identification of patients at high risk of MRSA colonisation
The change in infection control policy was determined
by the initial regression analysis that demonstrated the
factors associated with MRSA colonisation in the
cohort of patients admitted to the vascular unit
between November 2002 and April 2003. The factors
associated with MRSA carriage, colonisation and
infection are shown in Table 1.MRSA carriage, colonisation and infection rates
The rates of MRSA hospital acquired colonisation;
total colonisation (community acquired and hospitalTable 3. MRSA colonisation for the three time periods studied, for
all patients and by operative procedure
Period 1 Period 2 Period 3 p
All patients 66/367 19/199 13/211 !0.001
18% 9.5% 6.1%
Open AAA 12/28 0/9 1/14 0.0054
42.9% 0% 7.1%
EVAR 3/8 4/17 2/21 0.21
37.5% 23.5% 9.5%
All AAA 15/36 4/26 3/35 0.0023
41.7% 15.4% 8.6%
CEA 0/15 0/10 0/11 N/A
0% 0% 0%
Bypass 11/29 3/14 1/24 0.013
37.9% 21.4% 4.2%
Amputation 6/21 2/3 2/6 0.42
38.1% 66.7% 33.3%
PTA 15/124 5/57 6/48 0.78
12.1% 8.8% 12.5%
Period 1, November 2002–April 2003; period 2, August–December
2003; period 3, October 2004–January 2005. Numbers and percen-
tages are given. Statistical analysis used Fischer’s exact test.
Eur J Vasc Endovasc Surg Vol 31, June 2006acquired) and MRSA infection are tabulated in
Tables 2–4.
Data from the early time period demonstrated an
overall hospital acquired MRSA colonisation rate of
10.6%. In particular, the colonisation rates for patients
following abdominal aortic aneurysm repair (30%) or
lower limb bypass (31%) were considered highly
relevant due to the dire consequences of graft infection
following these forms of reconstruction.3,4 In this
period there were 39 MRSA infections. These com-
prised 32 cutaneous infections of surgical wounds or
areas of tissue loss, five episodes of MRSA pneumonia
and two patients with bacteraemia considered sec-
ondary to central line insertion. All these patients were
treated with intravenous vancomycin. In cases of
prosthetic graft insertion, antibiotics were continued
for 6 weeks. There were no prosthetic or autologous
graft infections.
The rates of MRSA colonisation and infection
decreased following the change in infection control
policy in July 2003. Analysis of MRSA rates from the
two disparate time period following July 2003
(August–December 2003 and October 2004–January
2005) demonstrated a significant reduction in the total
number of patients acquiring MRSA on the vascular
unit. Most significantly the rates of hospital acquired
MRSA colonisation following aortic or lower limb
procedures decreased significantly. In addition, the
rates of MRSA infection following aortic surgery were
reduced. In the second and third time periods studied
there were five (four cutaneous and one pneumonia)
and two (both cutaneous) MRSA infections, respect-
ively. Again, there were no MRSA graft infections.
Table 6. Factors independently associated with MRSA carriage,
colonisation and infection based on data from all time periods
studied
Hospital acquired
MRSA colonisation
MRSA colonisation MRSA infection
Length of stayO
7 days
MRSA carrier MRSA colonisation
System Length of stayO
7 days
System
ITU admission System Open AAA
ITU admission Tissue loss
Lower limb bypass
surgery
All factors are significant to p!0.01, and are presented in order of
significance. System, change in infection control policy; open AAA,
open abdominal aortic aneurysm repair. Variables included in
analysis of MRSA infection: age, admission type (emergency or
elective), length of stay, diagnosis (abdominal aortic aneurysm,
neurovascular disease, severe limb ischaemia, tissue loss, inter-
mittent claudication, varicose veins, other), diabetes, past history
MRSA, operative procedure (open aneurysm repair, endovascular
aneurysm repair, carotid endarterectomy, lower limb bypass,
amputation, PTA, vein surgery), ITU admission, MRSA carriage,
system.
Table 5. Clinical data for patients admitted to the vascular unit
during the three time periods studied
Period 1 Period 2 Period 3 p
Age
PH MRSA 27/367 16/199 10/211 0.38
7.1% 8.0% 4.7%
MRSA
admission
28/367 20/199 10/211 0.12
7.6% 10% 4.7%
Tissue loss 51/367 14/199 27/211 0.15
13.9% 7.0% 12.8%
SLI 72/367 15/199 28/211 0.0003
19.6% 7.5% 13.3%
AAA 86/367 67/199 73/211 0.029
23.4% 33.7% 34.6%
EVAR 10/47 18/27 21/36
21% 66% 58%
DM 52/367 42/199 31/211 0.01
14.2% 21.1% 14.7%
ITU 51/367 25/199 30/211 0.84
33.8% 12.6% 14.2%
Emergency
admission
124/367 36/199 30/211 0.0001
33.8% 18.1% 14.2%
Period 1, November 2002–April 2003; period 2, August 2003–
December 2003; period 3, October 2004–January 2005. Numbers and
percentages are given. Statistical analysis used Fischer’s exact test
for discrete variables and Mann–Whitney analysis for continuous
variables. PH MRSA, previous history of MRSA colonization/
infection; MRSA admission, MRSA isolated on admission screening
swabs; tissue loss, presence of tissue loss (ulceration, non-healing
wound); SLI, diagnosis of severe limb ischaemia (ischaemia rest pain
without tissue loss); AAA, diagnosis of abdominal aortic aneurysm;
EVAR, proportion of patients undergoing aneurysm repair treated
with an endovascular graft; DM, history of diabetes mellitus; ITU,
admission to the intensive care unit; emergency admission,
admission to the vascular unit via emergency route.
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Analysis of the data suggested that there were other
factors that may have influenced the MRSA rate in
addition to the change in infection control policy. The
clinical presentation of the patients in the three time
periods is illustrated in Table 5. These data demon-
strate that the proportion of patients with a past
history of MRSA remained relatively constant
throughout the three time periods analysed. Similarly,
the prevalence of patients with MRSA isolated on their
admission swabs (MRSA carriers) and the proportion
of patients with tissue loss (a risk factor for MRSA
colonisation) were not different during the periods
investigated. However, there appeared to be a
significant reduction in the proportion of patients
presenting with severe limb ischaemia, and a
reduction in the proportion of emergency admissions.
In addition, the proportion of patients with diabetes
appeared to increase as did the percentage of patients
undergoing endovascular surgery for abdominal
aortic aneurysms.In order to investigate whether any of these
differences could explain the reduction in MRSA
rates, all data was entered into a regression analysis
to determine the factors independently associated
with MRSA colonisation and infection over all time
periods. The change in isolation policy was entered
into the regression analysis as a possible confounding
factor. The results are tabulated in Table 6. The
regression analysis demonstrated that the factors
associated with MRSA colonisation and infection
remained similar to the factors identified on the initial
regression analysis (MRSA carriage, ITU admission,
long length of stay), but in addition, revealed that the
change in infection control policy was a significant
negative factor in MRSA acquisition.Discussion
Data obtained from the initial time period of this
investigation (November 2002–April 2003) confirmed
the findings of previous studies reporting MRSA rates
in vascular patients.5 The present study revealed that
7.6% of patients admitted to the vascular unit were
MRSA carriers and that a further 10.6% became
colonised within one hospital admission. Similar
findings were reported by Scriven et al. who demon-
strated that 4% of vascular patients admitted to
Leicester Royal Infirmary were MRSA carriers and
that 16 of 96 (17%) became colonised, with 10 (10%)
exhibiting MRSA infection.6Eur J Vasc Endovasc Surg Vol 31, June 2006
M. Thompson614Although the MRSA rates determined from the first
period of the present study were within previously
reported ranges, the spectrum of patients affected gave
considerable cause for concern. High rates of colonisa-
tion and infection were reported in patients under-
going aortic aneurysm repair and lower limb bypass.
Patients undergoing these forms of arterial reconstruc-
tion have poor outcomes in the presence of MRSA
infection. Murphy et al.5,8 reported mortality rates of
29% for infra-inguinal bypass and 56% for aortic
reconstruction when complicated by MRSA infection.
Similarly, Nasim et al.4 revealed mortality rates of 21
and 26% for aortic and lower limb surgery compli-
cated by MRSA infection. Given these adverse out-
comes it is essential that MRSA colonisation and
infection is reduced in vascular units.
Many strategies have been suggested to reduce
MRSA rates in vascular surgical patients.7 Appro-
priate antibiotic prophylaxis9 and meticulous aseptic
surgical techniques have no level 1 evidence, but
would seem to be mandatory. The use of antibiotic
impregnated grafts has no clinically proven efficacy
against MRSA, but the adoption of less invasive
surgical techniques hold promise for reducing vari-
ables associated with MRSA colonisation (e.g. length
of stay and ITU admission).
The role of isolation is attracting considerable
interest at present and forms the basis for the present
study. In some units, it has proved possible to isolate
all patients colonised or infected with MRSA from the
rest of the patient cohort. If sufficient isolation rooms
are available this can result in reduced MRSA rates.3
However, isolating all colonised patients does have
some difficulties. Sufficient isolation rooms must be
available which cannot usually be guaranteed. In
addition, although newer more rapid MRSA tests are
becoming available, there is often a delay between
swabbing patients and receiving the results. This delay
may allow patients colonised with MRSA to be in
contact with the general pool of vascular patients,
many of whom will be undergoing prosthetic
reconstruction.
The present study investigated the concept of
separating patients at low risk of MRSA from those
at higher risk, based on identification of factors
associated with MRSA colonisation. The initial
regression analysis performed in the present study
documented factors associated with in-hospital
MRSA carriage or in-hospital colonisation, which
were similar to those described previously.6 Patients
with these risk factors were then separated from
pre-operative or post-operative patients without
significant MRSA risk. This isolation policy made
the best use of available ward space in separatingEur J Vasc Endovasc Surg Vol 31, June 2006patients at high and low risk of MRSA. The change
in isolation policy appeared to have a dramatic
effect on MRSA rates with the incidence of MRSA
colonisation and infection being significantly
reduced in both time periods audited after the
change ward isolation policy. Most importantly,
MRSA colonisation and/or infection became a
comparatively rare event in patients undergoing
aortic or lower limb reconstruction.
The present study suggested that a change in
isolation policy may have dramatic effects on MRSA
acquisition. Several other studies in non-vascular
patients have reported similar outcomes,10,11 but
there are consistent problems with interpretation of
such investigations. Most trials studying the effect of
isolation policies on MRSA infection are interrupted
time series which record defined outcome measures
before and after a number of interventions. Analysis of
data from such studies is made more complex, as a
change in isolation policy rarely occurs as a single
event and there are usually a number of potential
confounding factors. This is well illustrated in the
present study, in which the change in isolation policy
was combined with a change in antibiotic prophylaxis,
a move toward endovascular aneurysm repair, a
decreased number of emergency admissions, and an
increase in the proportion of patients with diabetes. In
addition, the time period studied coincided with
increased public awareness of MRSA and government
initiatives to increase basic hand hygiene. Further
confounding factors may be present in seasonal effects,
change in MRSA strain types or in the increased
awareness of MRSA that came with discussion over a
change to ward policy.
With such a large number of possible confounding
factors it is not possible to state with absolute certainty
that the MRSA reductions reported in the present
study occurred due to the change in isolation policy.
However, all measurable variables were entered into a
regression analysis that suggested that the system of
isolation was significantly associated with reduced
MRSA colonisation and infection, whereas the change
in patient demographics and operative procedure
were not. It was not possible to separate the effect of
ward isolation policy from the change in antibiotic
policy which is a weakness of the study.
The change in isolation policy described in the
present investigation can be recommended as a
method to reduce MRSA colonisation and infection
in vascular units. The policy is relatively straightfor-
ward to institute and it is likely that the factors
associated with MRSA colonisation are likely to be
extrapolated across different units, so that similar
protocols may be adopted. The major disadvantage of
MRSA in Vascular Surgery 615the isolation system described in this study is that all
accommodation in the ward becomes mixed sex as
patients are allocated to bays dependent on their
MRSA risk not their gender. This is obviously not
ideal, but in a health system with finite resources,
decisions will continually need to be made balancing
bed configuration with infection risk.Contributors
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